Viba Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 616.99%
- Profit Growth 114.77%
- Ebitda 490.38%
- Net Worth 102.30%
- Total Assets -9.54%
About Viba Biosciences
Viba Biosciences Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 March 2016 (Eight years and 11 months 10 days old ). Its registered office is in Delhi, India.
The Corporate was formerly known as Vedant Biosciences Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Kharbanda and Varsha Kharbanda serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2016PTC291897
-
Company No.
291897
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Viba Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kharbanda
|
Director | 01-Mar-2016 | Current |
|
Varsha Kharbanda
|
Director | 01-Mar-2016 | Current |
Financial Performance of Viba Biosciences.
Viba Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 616.99% increase. The company also saw a substantial improvement in profitability, with a 114.77% increase in profit. The company's net worth Soared by an impressive increase of 102.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viba Biosciences?
In 2021, Viba Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jambul Enterprises Private LimitedAnil Kharbanda and Varsha Kharbanda are mutual person
-
V.S. Interchem Private Limited
Anil Kharbanda and Varsha Kharbanda are mutual person
-
Gkn Exim India.Private Limited
Anil Kharbanda and Varsha Kharbanda are mutual person
-
Savita Designs And Prints Private Limited
Varsha Kharbanda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Viba Biosciences?
Unlock and access historical data on people associated with Viba Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viba Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viba Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
